Life Sciences Investing

Thompson Street Capital Partners has announced it has acquired Vector Laboratories.

Vector, based in Burlingame, Calif., is the protein detection business unit of Maravai. Founded in 1976, the company manufacturers labeling and visual detection reagents for life science
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Thompson Street Acquires Vector Laboratories

Sixth Street has led an $830 million growth equity investment into Caris Life Sciences, according to a news release.

Caris, based in Irving, Texas, develops molecular profiling assays for oncology that scan DNA, RNA and proteins to reveal
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Sixth Street Leads $830 Million Investment Into Caris Life Sciences

The Carlyle Group has announced it has agreed to acquire Unchained Labs for $435 million.

Unchained Labs, based in Pleasanton, Calif., is a producer of life sciences tools. Founded in 2015, the company focuses on solving problems for biologics
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle Group Acquires Unchained Labs for $435 Million

NovaQuest Private Equity has announced it has acquired CoreRx.

CoreRx, based in Clearwater, Fla., is a contract development and manufacturing organization that serves small to mid-sized pharmaceutical and biotech organizations. Founded in 2006, the company offers preformulation, formulation, analytical
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: NovaQuest Acquires CoreRx

Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners (THL), according to a news release.

CSafe Global, based in Dayton, Ohio, is a provider of cold chain shipping solutions to global
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Frazier Healthcare Partners Acquires Stake in CSafe Global From THL

The Blackstone Group has announced the closing of its acquisition of Clarus. The business will now operate as Blackstone Life Sciences.

Blackstone indicated that its new private investment platform will invest across the lifecycle of companies and products within life
Continue Reading Blackstone Forms Life Sciences Investment Platform With Closing of Clarus Acquisition